2023
DOI: 10.1080/14737140.2023.2245567
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of neuroactive ligand–receptor interaction pathway can enhance immunotherapy response in colon cancer: an in silico study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…It encompasses interactions between the surface receptors of nerve cells and neurotransmitters, hormones, or other neuroactive substances(Y. Yang et al, 2023). This signaling pathway is critical in numerous physiological processes, including nerve conduction, neural development, and the regulation of emotions.…”
Section: Discussionmentioning
confidence: 99%
“…It encompasses interactions between the surface receptors of nerve cells and neurotransmitters, hormones, or other neuroactive substances(Y. Yang et al, 2023). This signaling pathway is critical in numerous physiological processes, including nerve conduction, neural development, and the regulation of emotions.…”
Section: Discussionmentioning
confidence: 99%
“…The fatty acid metabolism was thought to inhibit LYM pathways, such as CPT1A, a key enzyme in fatty acid b-oxidation, inhibits LYM under pathological conditions (25), which may provide new evidence for the mechanism of LYM in LUAD with low-LYM-index. In addition, cell adhesion molecules and neuroative ligand-receptor interactions were involved in tumor progression (26)(27)(28), as indicated by the fact that CEACAM1, a cell adhesion molecule, was associated with tumor angiogenesis and LYM (29). Therefore, these pathways may reveal the potential mechanism involved in the difference between the high-and low-LYM-index groups.…”
Section: Gsea Analysis Of Lym Indexmentioning
confidence: 99%